Avascular Necrosis Market – Overview
Global Avascular Necrosis Market that anticipates aggrandizement for this market at 6.58% CAGR (Compound Annual Growth Rate) between 2018 and 2024. Avascular Necrosis (AN) is often caused by joint or bone trauma, long-term alcohol abuse or steroid use.
The essential factors that contribute to the global avascular necrosis market growth are increased bone disorder worldwide and the rising global geriatric population. Other factors contributing to the market changing lifestyle, the focus of healthcare providers on providing low-cost treatment in regional markets, and increased prevalence of alcoholism and steroid use, especially among young adults and middle-aged individuals.
Request Sample Copy at https://www.marketresearchfuture.com/sample_request/6131
Key Players
The key players in the global avascular necrosis market include Bayer AG (Germany), Boehringer Ingelheim (Germany), Bristol-Myers Squibb (USA), Eli Lilly & Company (USA), Integra LifeSciences Corporation (USA), Medtronic PLC (Republic of Ireland), Merck KGaA (Germany), Pfizer Inc. (USA), Sanofi (France), and Zimmer Biomet Holdings (USA).
Latest Industry News
- Mumbai-based Regrow Biosciences has developed a cell therapy-based solution that can treat problems pertaining to the orthopedic joint. 14 NOV 2018
- FDA has granted Holland, Michigan-based Shoulder Innovations, LLC, a clearance for its InSet Humeral Short Stem System for shoulder arthroplasty that includes avascular necrosis of the humeral head. 14 NOV 2018
Segmentation:
The global avascular necrosis market has been segmented on the basis of diagnosis, end-user, treatment, type, site, and region. The segmentation as per diagnosis can segment this market into imaging and biopsy. Imaging commands more preference because it is minimally invasive, and is vital in the early diagnoses of the disease. Based on the end user, the market has been segmented into ambulatory surgical centers, diagnostic centers, and hospitals & clinics.
The treatment-based segmentation segments the market into electrical stimulation, gene therapy, medication, and surgery. Surgery is the leads the market because it is the only method of treatment that provides long-term relief. However, during the forecast period, gene therapy is expected to witness rapid growth.
By type, the market has been segmented into trauma-related avascular necrosis and non-trauma related avascular necrosis. Non-trauma related holds the larger share of the market due to increasing cases of alcoholism and illegal steroid use. With regards to site, Avascular necrosis usually occurs in the hip bone, knee, shoulder, and others. Hip bone subsegment holds the largest share of the market share.
Regional Analysis:
The regional segmentation of the global avascular necrosis market segments the market into regional markets known as The Americas (North America & South America), Europe, Asia Pacific, and the Middle East & Africa (MEA). The Americas is the leading regional market because North America alone holds the potential anyway to be the biggest regional market. In the Americas (primarily in North America), the market is growing due to the presence of the major market players in North America, especially the USA. Another important factor for market growth is the availability of advanced medical facilities in this region. Another important country-specific market in this region is Canada. South America is a smaller market compared to North America as the purchasing power of people is low. However, Argentina and Brazil are two strong economies in this region that can emerge as big markets in the near future.
Browse Complete 539 Pages Premium Research Report Enabled with 300+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/avascular-necrosis-market-6131
Europe is the second largest regional market. In this region, the market is growing due to the availability of government funding for research and development (R&D) activities, the presence of some key market players, and advanced medical facilities that are second only to North America. Remaining reasons for market growth are the same as those of North America. Due to the reasons same as the Americas, Western Europe is a bigger market than Eastern Europe. The most important country-specific markets in this region are France, Germany, Italy, Spain, and the UK, followed by the remaining countries of Western Europe and then Eastern Europe.
During the forecast period, the Asia Pacific is likely witnessing the highest growth as a regional market due to the increasing prevalence of the avascular necrosis in the emerging economies in this region. Another reason for market growth is the manufacturing of medical devices increasingly shifting to countries like China and India due to the availability of necessary infrastructure, cheap labor costs, and low investments. Other important country-specific markets in this region are Australia, Japan, and South Korea, followed by the remaining countries of the Asia Pacific region.
In the MEA region, the market is small and limited due to poor countries, lack of awareness, lack of advanced medical facilities, low standard of medical facilities, lack of education, lack of healthcare facilities, and most governments not considering healthcare a priority.
Major TOC of Avascular Necrosis Market Research Report – Forecast to 2024:
1 Executive Summary
2 Market Introduction
3 Research Methodology
4 Market Dynamics
5 Market Factor Analysis
6 Global Avascular Necrosis Market, by Type
7 Global Avascular Necrosis Market, by Site
8 Global Avascular Necrosis Market, by Diagnosis
9 Global Avascular Necrosis Market, by Treatment
10 Global Avascular Necrosis Market, by End-User
11 Global Avascular Necrosis Market, by Region
12 Competitive Landscape
13 Company Profiles
14 Conclusion
15 Appendix
Ask Any Question at https://www.marketresearchfuture.com/enquiry/6131
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/avascular-necrosis-market-6131